| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SERES THERAPEUTICS INC | 12,682,876 | 155,873,000 | 42.59% | ||
| 2 | SYROS PHARMACEUTICALS INC | 4,806,656 | 66,668,000 | 18.22% | ||
| 3 | AGIOS PHARMACEUTICALS INC | 965,369 | 50,991,000 | 13.93% | ||
| 4 | EDITAS MEDICINE INCORPORATED | 3,455,316 | 46,578,000 | 12.73% | ||
| 5 | SELECTA BIOSCIENCES INC | 1,651,862 | 23,539,000 | 6.43% | ||
| 6 | T2 BIOSYSTEMS INC | 2,176,167 | 15,756,000 | 4.30% | ||
| 7 | ELEVEN BIOTHERAPEUTICS INC | 2,354,710 | 6,594,000 | 1.80% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-16-001561, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
